Article
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
Clinical and experimental immunology - 1 Mar 2004
Walker L J, Aldhous M C, Drummond H E, Smith B R K, Nimmo E R, Arnott I D R, Satsangi J
Abstract excerpt
Anti-Saccharomyces cerevisiae antibodies (ASCAs) have been proposed as serological markers, which may differentiate Crohn's disease (CD) from ulcerative colitis (UC) and predict disease phenotype. Their importance in pathogenesis is unproven. We investigated the relationship between ASCAs, disease phenotype and NOD2/CARD15 genotype in CD and whether ASCAs were related to antibodies to other fungal proteins. Serum...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
